radioactive iodine
Sponsors
University of Helsinki, University of Sao Paulo, Sidney Kimmel Cancer Center at Thomas Jefferson University, Assiut University, Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Conditions
Autonomous Thyroid FunctionBreast CarcinomaDifferentiated Thyroid CancerHyperthyroidism/ThyrotoxicosisIodine Adverse ReactionIodine HyperthyroidismOvarian InsufficiencyRadiation Exposure
Phase 2
Metformin to Mitigate Sequelae of Radioactive Iodine Treatment for Thyroid Cancers
TerminatedNCT03109847
Start: 2017-01-05End: 2022-12-07Updated: 2025-12-11
The Safety and Effectiveness of rhTSH in Radioiodine Treatment for Patients With Differentiated Thyroid Cancer.
NCT04447183
Start: 2020-11-23End: 2024-10-31Target: 120Updated: 2023-10-23
Phase 3
The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy
NCT00115895
Start: 2000-01-31End: 2020-09-30Updated: 2018-03-02
Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules
TerminatedNCT05142904
Start: 2021-11-17End: 2024-11-01Updated: 2025-07-17
Phase 4
Unknown Phase
Three-Year Follow-up of Radioiodine Therapy for Goitre
CompletedNCT00509483
Start: 2002-01-31End: 2006-12-31Target: 40Updated: 2008-10-17
Effect of Radioiodine Therapy on Ovarian Reserve in Female Patients With Differentiated Thyroid Cancer
NCT04396158
Start: 2020-06-15End: 2021-12-15Target: 38Updated: 2020-05-27
An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer
Active, not recruitingNCT04871139
Start: 2021-04-08End: 2028-03-01Target: 100Updated: 2026-03-27